Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gilead Sciences, Inc. (GILD) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Gilead Sciences, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 882095.
Total stock buying since 2015: $999,150.
Total stock sales since 2015: $904,439,192.
Total stock option exercises since 2015: $229,467,536.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 435,785 | $45,394,173 | 430,175 | $23,889,837 |
| 2024 | 0 | $0 | 553,812 | $50,082,191 | 602,474 | $29,785,219 |
| 2023 | 0 | $0 | 32,096 | $2,551,890 | 146,531 | $442,191 |
| 2022 | 0 | $0 | 26,355 | $1,866,288 | 194,847 | $828,297 |
| 2021 | 0 | $0 | 66,560 | $4,452,843 | 172,673 | $1,756,865 |
| 2020 | 0 | $0 | 137,004 | $9,885,521 | 248,984 | $3,686,488 |
| 2019 | 0 | $0 | 128,408 | $8,418,483 | 159,162 | $2,742,587 |
| 2018 | 0 | $0 | 926,935 | $70,384,176 | 1,254,464 | $30,546,376 |
| 2017 | 0 | $0 | 1,447,128 | $107,862,022 | 1,498,305 | $32,405,995 |
| 2016 | 0 | $0 | 2,050,842 | $174,107,762 | 2,026,940 | $36,648,094 |
| 2015 | 10,000 | $999,150 | 4,020,793 | $429,433,843 | 3,952,353 | $66,735,587 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-03-20 | Cogan John Francis (Director) | Option Ex | 2,700 | 22.02 | 59,440 |
| 2019-02-19 | Wilson Gayle E (Director) | Sale | 19,068 | 67.08 | 1,279,081 |
| 2019-02-19 | Wilson Gayle E (Director) | Option Ex | 19,068 | .00 | 0 |
| 2019-01-31 | Barton Jacqueline K (Director) | Option Ex | 480 | .00 | 0 |
| 2018-12-03 | Martin John C (Director) | Sale | 50,000 | 71.84 | 3,592,000 |
| 2018-12-03 | Martin John C (Director) | Option Ex | 50,000 | 23.60 | 1,180,000 |
| 2018-11-27 | Milligan John F (President and CEO) | Option Ex | 280,000 | 23.60 | 6,608,000 |
| 2018-11-10 | Mchutchison John G (Chief Scientific Off/HeadR&D) | Option Ex | 1,465 | .00 | 0 |
| 2018-11-01 | Martin John C (Director) | Sale | 50,000 | 69.43 | 3,471,550 |
| 2018-11-01 | Martin John C (Director) | Option Ex | 50,000 | 23.60 | 1,180,000 |
| 2018-10-01 | Martin John C (Director) | Sale | 50,000 | 78.12 | 3,905,850 |
| 2018-10-01 | Martin John C (Director) | Option Ex | 50,000 | 23.60 | 1,180,000 |
| 2018-09-04 | Martin John C (Director) | Sale | 50,000 | 74.56 | 3,727,750 |
| 2018-09-04 | Martin John C (Director) | Option Ex | 50,000 | 23.60 | 1,180,000 |
| 2018-08-10 | Pletcher Brett A (EVP, Gen Counsel & Corp Sec) | Option Ex | 1,070 | .00 | 0 |
| 2018-08-01 | Martin John C (Director) | Sale | 50,000 | 77.85 | 3,892,649 |
| 2018-08-01 | Martin John C (Director) | Option Ex | 50,000 | 23.60 | 1,180,000 |
| 2018-07-31 | Pletcher Brett A (EVP, Gen Counsel & Corp Sec) | Option Ex | 2,000 | .00 | 0 |
| 2018-07-02 | Martin John C (Director) | Sale | 50,000 | 71.08 | 3,554,050 |
| 2018-07-02 | Martin John C (Director) | Option Ex | 50,000 | 23.60 | 1,180,000 |
| 2018-06-01 | Martin John C (Director) | Sale | 50,000 | 68.13 | 3,406,500 |
| 2018-06-01 | Martin John C (Director) | Option Ex | 50,000 | 23.60 | 1,180,000 |
| 2018-05-08 | Cogan John Francis (Director) | Option Ex | 2,241 | .00 | 0 |
| 2018-05-08 | Wilson Gayle E (Director) | Option Ex | 2,241 | .00 | 0 |
| 2018-05-08 | Wold Olsen Per (Director) | Option Ex | 2,241 | .00 | 0 |
| 2018-05-04 | Cogan John Francis (Director) | Sale | 5,836 | 65.09 | 379,882 |
| 2018-05-04 | Cogan John Francis (Director) | Option Ex | 5,836 | 26.61 | 155,325 |
| 2018-05-04 | Milligan John F (President and CEO) | Option Ex | 80,000 | 27.07 | 2,165,600 |
| 2018-05-01 | Martin John C (Director) | Sale | 50,000 | 72.19 | 3,609,650 |
| 2018-05-01 | Martin John C (Director) | Option Ex | 50,000 | 23.60 | 1,180,000 |
| 2018-04-27 | Cogan John Francis (Director) | Sale | 5,833 | 73.91 | 431,117 |
| 2018-04-27 | Cogan John Francis (Director) | Option Ex | 5,833 | 26.61 | 155,245 |
| 2018-04-20 | Cogan John Francis (Director) | Sale | 5,833 | 73.58 | 429,203 |
| 2018-04-20 | Cogan John Francis (Director) | Option Ex | 5,833 | 26.61 | 155,245 |
| 2018-04-13 | Cogan John Francis (Director) | Sale | 5,833 | 75.56 | 440,741 |
| 2018-04-13 | Cogan John Francis (Director) | Option Ex | 5,833 | 26.61 | 155,245 |
| 2018-04-06 | Cogan John Francis (Director) | Sale | 5,833 | 74.47 | 434,383 |
| 2018-04-06 | Cogan John Francis (Director) | Option Ex | 5,833 | 26.61 | 155,245 |
| 2018-04-02 | Cogan John Francis (Director) | Sale | 5,833 | 74.93 | 437,066 |
| 2018-04-02 | Cogan John Francis (Director) | Option Ex | 5,833 | 26.61 | 155,245 |
| 2018-04-02 | Martin John C (Director) | Sale | 50,000 | 73.80 | 3,690,050 |
| 2018-04-02 | Martin John C (Director) | Option Ex | 50,000 | 23.60 | 1,180,000 |
| 2018-03-23 | Cogan John Francis (Director) | Sale | 5,833 | 75.02 | 437,585 |
| 2018-03-23 | Cogan John Francis (Director) | Option Ex | 5,833 | 26.61 | 155,245 |
| 2018-03-16 | Cogan John Francis (Director) | Sale | 5,833 | 80.08 | 467,135 |
| 2018-03-16 | Cogan John Francis (Director) | Option Ex | 5,833 | 26.61 | 155,245 |
| 2018-03-12 | Cogan John Francis (Director) | Sale | 5,833 | 80.93 | 472,064 |
| 2018-03-12 | Cogan John Francis (Director) | Option Ex | 5,833 | 26.61 | 155,245 |
| 2018-03-01 | Alton Gregg H (EVP,Corporate &Medical Affairs) | Sale | 25,000 | 78.66 | 1,966,500 |
| 2018-03-01 | Alton Gregg H (EVP,Corporate &Medical Affairs) | Option Ex | 17,250 | 40.56 | 699,660 |
| 2018-03-01 | Moore Nicholas G (Director) | Option Ex | 178 | .00 | 0 |
| 2018-03-01 | Martin John C (Executive Chairman) | Sale | 50,000 | 78.76 | 3,938,100 |
| 2018-03-01 | Martin John C (Executive Chairman) | Option Ex | 50,000 | 23.60 | 1,180,000 |
| 2018-02-28 | Washington Robin L (EVP, CFO) | Sale | 5,000 | 80.31 | 401,565 |
| 2018-02-20 | Alton Gregg H (EVP,Corporate &Medical Affairs) | Sale | 14,435 | 81.54 | 1,176,986 |
| 2018-02-10 | Young Kevin (Chief Operating Officer) | Option Ex | 908 | .00 | 0 |
| 2018-02-09 | Wilson Gayle E (Director) | Sale | 60,000 | 77.92 | 4,675,080 |
| 2018-02-09 | Wilson Gayle E (Director) | Option Ex | 60,000 | 26.61 | 1,596,900 |
| 2018-02-01 | Alton Gregg H (EVP,Corporate &Medical Affairs) | Sale | 25,000 | 83.47 | 2,086,850 |
| 2018-02-01 | Alton Gregg H (EVP,Corporate &Medical Affairs) | Option Ex | 17,250 | 40.56 | 699,660 |
| 2018-02-01 | Young Kevin (Chief Operating Officer) | Option Ex | 620 | .00 | 0 |
| 2018-02-01 | Martin John C (Executive Chairman) | Sale | 50,000 | 83.52 | 4,175,900 |
| 2018-02-01 | Martin John C (Executive Chairman) | Option Ex | 50,000 | 23.60 | 1,180,000 |
| 2018-01-16 | Meyers James R (EVP Worldwide Commercial Ops) | Sale | 100,000 | 80.49 | 8,049,400 |
| 2018-01-16 | Meyers James R (EVP Worldwide Commercial Ops) | Option Ex | 100,000 | 21.57 | 2,157,500 |
| 2018-01-11 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Sale | 30,000 | 79.00 | 2,370,000 |
| 2018-01-11 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Option Ex | 25,875 | 32.73 | 846,966 |
| 2018-01-02 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Sale | 15,000 | 73.40 | 1,100,970 |
| 2018-01-02 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Option Ex | 8,625 | 24.91 | 214,805 |
| 2018-01-02 | Martin John C (Executive Chairman) | Sale | 50,000 | 73.27 | 3,663,600 |
| 2018-01-02 | Martin John C (Executive Chairman) | Option Ex | 50,000 | 23.60 | 1,180,000 |
| 2017-12-01 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Sale | 15,000 | 74.83 | 1,122,435 |
| 2017-12-01 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Option Ex | 8,625 | 24.91 | 214,805 |
| 2017-12-01 | Martin John C (Executive Chairman) | Sale | 73,333 | 75.01 | 5,500,708 |
| 2017-12-01 | Martin John C (Executive Chairman) | Option Ex | 73,333 | 21.57 | 1,582,159 |
| 2017-11-13 | Milligan John F (President and CEO) | Sale | 220,000 | 72.89 | 16,034,700 |
| 2017-11-13 | Milligan John F (President and CEO) | Option Ex | 220,000 | 21.57 | 4,746,500 |
| 2017-11-05 | Meyers James R (EVP Worldwide Commercial Ops) | Option Ex | 4,500 | .00 | 0 |
| 2017-11-01 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Sale | 15,000 | 75.11 | 1,126,665 |
| 2017-11-01 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Option Ex | 8,625 | 24.91 | 214,805 |
| 2017-11-01 | Martin John C (Executive Chairman) | Sale | 73,333 | 75.34 | 5,525,054 |
| 2017-11-01 | Martin John C (Executive Chairman) | Option Ex | 73,333 | 21.57 | 1,582,159 |
| 2017-10-02 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Sale | 25,000 | 82.68 | 2,067,000 |
| 2017-10-02 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Option Ex | 17,250 | 24.91 | 429,611 |
| 2017-10-02 | Martin John C (Executive Chairman) | Sale | 73,333 | 82.22 | 6,029,292 |
| 2017-10-02 | Martin John C (Executive Chairman) | Option Ex | 73,333 | 21.57 | 1,582,159 |
| 2017-09-07 | Washington Robin L (EVP, CFO) | Sale | 51,820 | 85.00 | 4,404,700 |
| 2017-09-07 | Washington Robin L (EVP, CFO) | Option Ex | 33,750 | 24.30 | 819,956 |
| 2017-09-01 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Sale | 25,000 | 83.25 | 2,081,325 |
| 2017-09-01 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Option Ex | 17,250 | 24.91 | 429,611 |
| 2017-09-01 | Martin John C (Executive Chairman) | Sale | 73,333 | 83.23 | 6,103,725 |
| 2017-09-01 | Martin John C (Executive Chairman) | Option Ex | 73,333 | 21.57 | 1,582,159 |
| 2017-08-31 | Meyers James R (EVP Worldwide Commercial Ops) | Sale | 60,000 | 83.33 | 4,999,620 |
| 2017-08-31 | Meyers James R (EVP Worldwide Commercial Ops) | Option Ex | 60,000 | 21.00 | 1,260,000 |
| 2017-08-30 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Sale | 50,000 | 79.00 | 3,950,000 |
| 2017-08-30 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Option Ex | 43,125 | 25.95 | 1,118,964 |
| 2017-08-19 | Kramer Kelly A. (Director) | Option Ex | 1,339 | .00 | 0 |
| 2017-08-10 | Meyers James R (EVP Worldwide Commercial Ops) | Option Ex | 820 | .00 | 0 |
| 2017-08-10 | Young Kevin (Chief Operating Officer) | Option Ex | 910 | .00 | 0 |
| 2017-08-01 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Sale | 15,000 | 75.88 | 1,138,185 |
| 2017-08-01 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Option Ex | 8,625 | 26.99 | 232,788 |
| 2017-08-01 | Martin John C (Executive Chairman) | Sale | 73,333 | 75.86 | 5,562,748 |
| 2017-08-01 | Martin John C (Executive Chairman) | Option Ex | 73,333 | 21.57 | 1,582,159 |
| 2017-07-21 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Sale | 40,000 | 74.00 | 2,960,000 |
| 2017-07-21 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Option Ex | 34,500 | 26.99 | 931,155 |
| 2017-07-03 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Sale | 5,000 | 71.06 | 355,295 |
| 2017-07-03 | Martin John C (Executive Chairman) | Sale | 73,333 | 71.00 | 5,206,862 |
| 2017-07-03 | Martin John C (Executive Chairman) | Option Ex | 73,333 | 21.57 | 1,582,159 |
| 2017-06-01 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Sale | 5,000 | 65.02 | 325,115 |
| 2017-06-01 | Martin John C (Executive Chairman) | Sale | 73,333 | 65.24 | 4,784,538 |
| 2017-06-01 | Martin John C (Executive Chairman) | Option Ex | 73,333 | 21.57 | 1,582,159 |
| 2017-05-09 | Lofton Kevin E (Director) | Option Ex | 1,787 | .00 | 0 |
| 2017-05-09 | Cogan John Francis (Director) | Sale | 9,943 | 67.25 | 668,666 |
| 2017-05-09 | Cogan John Francis (Director) | Option Ex | 16,787 | 10.35 | 173,795 |
| 2017-05-09 | Wilson Gayle E (Director) | Option Ex | 1,787 | .00 | 0 |
| 2017-05-09 | Wold Olsen Per (Director) | Option Ex | 1,787 | .00 | 0 |
| 2017-05-09 | Madigan John W (Director) | Option Ex | 1,787 | .00 | 0 |
| 2017-05-01 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Sale | 5,000 | 68.31 | 341,530 |
| 2017-05-01 | Martin John C (Executive Chairman) | Sale | 73,333 | 68.31 | 5,009,450 |
| 2017-05-01 | Martin John C (Executive Chairman) | Option Ex | 73,333 | 21.57 | 1,582,159 |
| 2017-04-03 | Martin John C (Executive Chairman) | Sale | 73,333 | 67.46 | 4,946,750 |
| 2017-04-03 | Martin John C (Executive Chairman) | Option Ex | 73,333 | 21.57 | 1,582,159 |
| 2017-03-30 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Sale | 5,000 | 67.48 | 337,390 |
| 2017-03-01 | Moore Nicholas G (Director) | Option Ex | 173 | .00 | 0 |
| 2017-03-01 | Martin John C (Executive Chairman) | Sale | 73,333 | 70.38 | 5,161,176 |
| 2017-03-01 | Martin John C (Executive Chairman) | Option Ex | 73,333 | 21.57 | 1,582,159 |
| 2017-02-23 | Wilson Gayle E (Director) | Sale | 20,365 | 69.30 | 1,411,375 |
| 2017-02-23 | Wilson Gayle E (Director) | Option Ex | 33,350 | 20.70 | 690,511 |
| 2017-02-23 | Milligan John F (President and CEO) | Option Ex | 100,000 | 21.57 | 2,157,500 |
| 2017-02-10 | Young Kevin (Chief Operating Officer) | Option Ex | 908 | .00 | 0 |
| 2017-02-01 | Young Kevin (Chief Operating Officer) | Option Ex | 620 | .00 | 0 |
| 2017-02-01 | Martin John C (Executive Chairman) | Sale | 73,333 | 72.57 | 5,322,069 |
| 2017-02-01 | Martin John C (Executive Chairman) | Option Ex | 73,333 | 21.57 | 1,582,159 |
| 2017-01-03 | Martin John C (Executive Chairman) | Sale | 73,337 | 73.44 | 5,385,649 |
| 2017-01-03 | Martin John C (Executive Chairman) | Option Ex | 73,337 | 21.57 | 1,582,245 |
| 2016-12-01 | Wilson Gayle E (Director) | Option Ex | 4,294 | .00 | 0 |
| 2016-11-18 | Madigan John W (Director) | Sale | 105,000 | 74.86 | 7,860,090 |
| 2016-11-18 | Madigan John W (Director) | Option Ex | 105,000 | 20.70 | 2,174,025 |
| 2016-11-09 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Sale | 10,000 | 79.00 | 790,000 |
| 2016-11-01 | Martin John C (Executive Chairman) | Sale | 100,000 | 73.94 | 7,394,400 |
| 2016-11-01 | Martin John C (Executive Chairman) | Option Ex | 100,000 | 16.39 | 1,639,500 |
| 2016-10-03 | Martin John C (Executive Chairman) | Sale | 100,000 | 78.09 | 7,809,500 |
| 2016-10-03 | Martin John C (Executive Chairman) | Option Ex | 100,000 | 16.39 | 1,639,500 |
| 2016-09-22 | Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff) | Sale | 5,000 | 81.84 | 409,219 |
| 2016-09-06 | Milligan John F (President and CEO) | Sale | 70,000 | 77.74 | 5,442,080 |
| 2016-09-06 | Milligan John F (President and CEO) | Option Ex | 70,000 | 20.74 | 1,451,800 |
| 2016-09-01 | Martin John C (Executive Chairman) | Sale | 100,000 | 77.82 | 7,782,200 |
| 2016-09-01 | Martin John C (Executive Chairman) | Option Ex | 100,000 | 16.39 | 1,639,500 |
| 2016-08-24 | Lofton Kevin E (Director) | Sale | 3,500 | 81.97 | 286,898 |
| 2016-08-01 | Carter Paul Rutherford (EVP Commercial Ops) | Sale | 2,000 | 79.81 | 159,620 |
Insider trading activities including stock purchases, stock sales, and option exercises of GILD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Gilead Sciences, Inc. (symbol GILD, CIK number 882095) see the Securities and Exchange Commission (SEC) website.